MedPath

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Phase 2
Conditions
Sepsis
Interventions
Drug: Rheum Palmatum Root
Registration Number
NCT03048903
Lead Sponsor
CHEN De-chang
Brief Summary

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Detailed Description

Patients were randomly divided into two groups, using rhubarb powder or placebo. Rhubarb is commercially certified rhubarb(Rheum palmatum, Sichuan origin, provided by the pharmacy of my hospital), ground into a powder, over 80 mesh steel mesh, Two days before 6g, three times / day, oral or nasal feeding, two days later reduced to 3g, three times / day, oral or nasal feeding; Another group of patients taking placebo, with the same dose of Rhubarb; The overall course of the two drugs was a week.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  1. Age:18-65 year old;
  2. Diagnosis: sepsis with gastrointestinal dysfunction (II-III grade AGI); gastrointestinal dysfunction after trauma (II-III AGI);
  3. Complete gastrointestinal tract anatomic structure(including the ileum and colon stoma)
Exclusion Criteria
  1. Hemodynamic instability;
  2. Underlying diseases: cardiac function III~IV, chronic liver dysfunction Child-Pugh score >9 points;
  3. Less than 5 days after surgery for stomach and small intestine,less than 7 days after Colonic surgery, Postoperative gastrointestinal leakage;
  4. Abdominal Compartment Syndrome;
  5. mechanical ileus
  6. active gastrointestinal hemorrhage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Starch CornStarch CornMedical Starch is harmless to people
Rheum Palmatum RootRheum Palmatum RootRheum Palmatum Root is commercially certified rhubarb(Rheum palmatum ,Sichuan origin, provided by the pharmacy of my hospital)
Primary Outcome Measures
NameTimeMethod
The remission rate of gastrointestinal dysfunction2 weeks

The rate of patients who can tolerate 1000Kcal whole protein enteral nutrition in all subjects

Secondary Outcome Measures
NameTimeMethod
The ratios of L/M in human urine samples7 days

The ratios oflactulose / mannitol in human urine samples

D- lactic acid7 days

The contents of citrulline in human serum samples

citrulline7 days

The contents of citrulline in human serum samples

Trial Locations

Locations (1)

Shanghai ChangZheng Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath